Twist uses four novel VHH methods that combine synthetic and natural approaches to maximize diversity, creating highquality VHH libraries for use against any protein target. These proprietary, naïve single chain domain libraries are ideal for initiating antibody discovery and development. Their modular nature supports creation of bi- or multi-specific antibodies ideal for developing next generation therapies.